Showing 2,081 - 2,100 results of 8,597 for search 'effective dysfunction', query time: 0.13s Refine Results
  1. 2081

    Association between the lymphocyte-to-high-density lipoprotein ratio and metabolic dysfunction-associated steatotic liver disease among US adults: a cross-sectional study from NHAN... by Chuanzhi Tang, Dadi Peng, Kezhen Zong, Zhongjun Wu, Miao Gong, Hui Li, Zuotian Huang, Shanshan Li

    Published 2024-12-01
    “…Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a liver disease that is strongly associated with chronic low-grade inflammation. …”
    Get full text
    Article
  2. 2082

    Ghrelin/GHSR Axis Induced M2 Macrophage and Alleviated Intestinal Barrier Dysfunction in a Sepsis Rat Model by Inactivating E2F1/NF-κB Signaling by Lei Zhu, Zhimin Dou, Wei Wu, Qiliang Hou, Sen Wang, Ziqian Yuan, Bin Li, Jian Liu

    Published 2023-01-01
    “…Our research is to investigate the regulatory effect and molecular mechanism of the ghrelin/GHSR axis on intestinal dysfunction and macrophage polarization in septic rats. …”
    Get full text
    Article
  3. 2083
  4. 2084

    Casein Kinase 2α Ablation Confers Protection Against Metabolic Dysfunction‐Associated Steatotic Liver Disease: Role of FUN14 Domain Containing 1‐Dependent Regulation of Mitophagy a... by Ke He, Meixiao Zhan, Xuanming Luo, Ruibing Li, Ling Lin, Jie Lin, Liheng Li, Hongdong Chen, Gary D. Lopaschuk, Hao Zhou, Fei Liu, Jun Ren

    Published 2025-07-01
    “…ABSTRACT Mitochondrial dyshomeostasis provokes the onset of metabolic dysfunction‐associated steatotic liver disease (MASLD) although its precise involvement in particular mitophagy in MASLD remains elusive. …”
    Get full text
    Article
  5. 2085

    Muscle-derived factor alleviated cognitive impairment caused by intestinal ischemia-reperfusion by Yafang Tan, Guo Mu, Feixiang Wang, Xin Fan, Chengjie Yang, Zuan Shi, Yiping Bai, Bingqing Xie, Xuan Yu, Jianguo Feng, Jing Jia, Xiaobin Wang, Ye Chen, Jun Zhou

    Published 2025-07-01
    “…Intestinal ischemia/reperfusion (II/R) is a common and grave clinical event, with high morbidity and mortality which can cause cerebral dysfunctions. There are no ideal prevention and treatment measures yet. …”
    Get full text
    Article
  6. 2086

    Molecular Biomarkers for Timely and Personalized Prediction of Maternal-Fetal Health Risk by Daniel Estrela, Rita F. Santos, Alice Masserdotti, Antonietta Silini, Ornella Parolini, Inês Mendes Pinto, Andrea Cruz

    Published 2025-02-01
    “…Challenges in developing molecular biomarker profiling include pinpointing specific molecular changes in the placenta linked to pathologies, timing predictions of conditions before clinical onset, and understanding how placental dysfunction affects maternal metabolism. Validating specific biomarkers and integrating them effectively into clinical practice requires further research. …”
    Get full text
    Article
  7. 2087

    Allogeneic CD4 T Cells Sustain Effective BK Polyomavirus-Specific CD8 T Cell Response in Kidney Transplant Recipients by Manon Dekeyser, Marie-Ghislaine de Goër de Herve, Houria Hendel-Chavez, Romain Lhotte, Ivan Scriabine, Karen Bargiel, Emmanuelle Boutin, Florence Herr, Jean-Luc Taupin, Yassine Taoufik, Antoine Durrbach

    Published 2024-08-01
    “…Conclusion: Our findings suggest that in KTRs, allogeneic CD4 T cells can help to maintain an effective BKPyV-specific CD8 T cell response that better controls BKPyV replication in the kidney allograft and may protect against BKPyVAN.…”
    Get full text
    Article
  8. 2088
  9. 2089

    Association of Neutrophil/High-Density Lipoprotein Cholesterol Ratio with Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus Patients: A Cross-Sec... by Li W, Tang H, Tong X, Zhao Y, Li S

    Published 2025-07-01
    “…The area under the curve (AUC) of the novel prediction model constructed on the basis of NHR reached 0.78 (95% CI 0.75– 0.82), which can be used to predict the onset of MASLD, and is effective in clinical applications.Conclusion: NHR is significantly correlated with MASLD, and NHR has the potential to be an early detection and intervention indicator for screening T2DM patients for MASLD.Keywords: neutrophil/high-density lipoprotein cholesterol ratio, type 2 diabetes mellitus, metabolic dysfunction-associated steatotic liver disease…”
    Get full text
    Article
  10. 2090

    Update on Diagnosis and Treatment for Levator Avulsion by Jenn-Ming Yang, Wen-Chen Huang

    Published 2025-04-01
    “…This article intends to discover the effective treatment for LA from the literature.…”
    Get full text
    Article
  11. 2091
  12. 2092
  13. 2093

    Global, regional, and national time trends in prevalence of metabolic dysfunction associated steatotic liver disease among women of reproductive age: an age-period-cohort analysis... by Jiehua Wei, Shanyu Lin, Senmao Zhang, Luying Fan, Lisa Jiang, Fan Xia, Ziye Li, Lizhang Chen, Zhiyong Zou, Tingting Wang

    Published 2025-12-01
    “…Objective This study aims to investigate the time trends in the prevalence of metabolic dysfunction associated steatotic liver disease (MASLD) among women of reproductive age (WRA) globally, regionally, and nationally from 1992 to 2021, and to explore associations with age, period, and birth cohort effects.Methods MASLD prevalence estimates were sourced from the Global Burden of Disease (GBD) 2021 study. …”
    Get full text
    Article
  14. 2094

    Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, op... by Minyoung Lee, Sukchul Hong, Yongin Cho, Hyungjin Rhee, Min Heui Yu, Jaehyun Bae, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha

    Published 2025-05-01
    “…This study aimed to investigate the complementary effects of combination therapy with pioglitazone (PIO) and empagliflozin (EMPA) on MASLD in individuals with type 2 diabetes. …”
    Get full text
    Article
  15. 2095

    Efficacy of biofeedback, repetitive transcranial magnetic stimulation and pelvic floor muscle training for female neurogenic bladder dysfunction after spinal cord injury: a study p... by Qing Zhang, Li Chen, Chengqi He, Feng Xiong, Lin Xu, Chenying Fu, Lihong Peng, Zejun Liang, Quan Wei

    Published 2020-08-01
    “…Therefore, this study aims to provide a detailed rationale and methodology for comparing the effectiveness of PFMT, biofeedback and repetitive transcranial magnetic stimulation (rTMS) as adjunct treatments for neurogenic bladder dysfunction.Methods and analysis This trial is a single-centre randomised controlled trial for female patients with urinary incontinence (UI) in phase of chronic SCI. …”
    Get full text
    Article
  16. 2096
  17. 2097
  18. 2098

    Identification of pediatric MASLD using insulin resistance indices by Kyungchul Song, Eunju Lee, Hye Sun Lee, Young Hoon Youn, Su Jung Baik, Hyun Joo Shin, Hyun Wook Chae, Ji-Won Lee, Yu-Jin Kwon

    Published 2025-07-01
    “…Impact and implications: The increasing prevalence of pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) and its strong association with cardiometabolic risk factors underscore the need for effective early detection tools. …”
    Get full text
    Article
  19. 2099
  20. 2100